Synthaverse (WAR:SVE) FFO


WAR:SVE Synthaverse SA WAR:SVE
55 GF Score
Price zł2.66
GF Value zł3.04
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Synthaverse FFO?

FFO (Funds from operations) only applies to REITs.

WAR:SVE
55GF Score
Synthaverse SA WAR:SVE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Synthaverse (WAR:SVE) Overvalued in 2026?

Based on GuruFocus' analysis, Synthaverse stock appears to be undervalued. The current stock price of zł2.66 is trading 12.7% below its estimated GF Value™ of zł3.04. GuruFocus considers Synthaverse to be Modestly Undervalued.

Key valuation signals for WAR:SVE:

  • FFO:
  • GF Value™: zł3.04 vs. price of zł2.66 (12.7% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the WAR:SVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthaverse Business Description

Other Exchanges 6NQ:Germany
Address 10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
55GF Score

Get the complete analysis for WAR:SVE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.66
Price
zł3.04
GF Value